Home
Diseases
HIV-1
Clinical Trials

Clinical Trials Related to HIV-1

Related studies linked through entity extraction aliases.

A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan Africa

Status: TERMINATED
Phase: PHASE2

Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

Status: COMPLETED
Phase: PHASE1

Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults

Status: COMPLETED
Phase: PHASE1

Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)

Status: COMPLETED
Phase: PHASE2

Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla

Status: COMPLETED
Phase: PHASE4

HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

Status: COMPLETED
Phase: PHASE4

Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen

Status: COMPLETED
Phase: PHASE2/PHASE3

Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)

Status: COMPLETED
Phase: PHASE3

A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)

Status: COMPLETED
Phase: PHASE1

Multiple Dose BE Study With Nevirapine 400mg PR Tablets

Status: COMPLETED
Phase: PHASE1

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Status: COMPLETED
Phase: PHASE3

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Status: COMPLETED
Phase: N/A

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

Status: COMPLETED
Phase: PHASE4

Korean Post-marketing Surveillance for Reyataz®

Status: COMPLETED
Phase: N/A

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Status: TERMINATED
Phase: PHASE3

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

Status: COMPLETED
Phase: PHASE4

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Status: TERMINATED
Phase: PHASE2

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Status: COMPLETED
Phase: PHASE4

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

Status: COMPLETED
Phase: PHASE2

Intrauterine Insemination In HIV-Discordant Couples

Status: TERMINATED
Phase: NA